Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Billes, Viktora | Kovács, Tibora; b | Hotzi, Bernadettea; b | Manzéger, Annab | Tagscherer, Kingab | Komlós, Marcella | Tarnóci, Annaa | Pádár, Zsolta | Erdős, Attilaa | Bjelik, Annamariac | Legradi, Adamc | Gulya, Károlyc | Gulyás, Balázsd; e; f | Vellai, Tibora; b; *
Affiliations: [a] Velgene Biotechnology Research Ltd., Szeged, Hungary | [b] Department of Genetics, Eötvös Loránd University, Budapest, Hungary | [c] Department of Cell Biology and Molecular Medicine, University of Szeged, Szeged, Hungary | [d] Karolinska Institute, Department of Clinical Neuroscience, Stockholm, Sweden | [e] Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore | [f] Imperial College London, Department of Medicine, Division of Brain Sciences, London, UK
Correspondence: [*] Correspondence to: T. Vellai, Department of Genetics, Eötvös Loránd University, Pázmány Péter stny. 1/C, Budapest, H-1117, Hungary. Tel.: +36 1 372 2500, Ext: 8684; Fax: +36 1 372 2641; E-mail: vellai@falco.elte.hu.
Abstract: Background: Autophagy, a lysosome-mediated self-degradation process of eukaryotic cells, serves as a main route for the elimination of cellular damage [1–3]. Such damages include aggregated, oxidized or misfolded proteins whose accumulation can cause various neurodegenerative pathologies, including Huntington’s disease (HD). Objective: Here we examined whether enhanced autophagic activity can alleviate neurophatological features in a Drosophila model of HD (the transgenic animals express a human mutant Huntingtin protein with a long polyglutamine repeat, 128Q). Methods: We have recently identified an autophagy-enhancing small molecule, AUTEN-67 (autophagy enhancer 67), with potent neuroprotective effects [4]. AUTEN-67 was applied to induce autophagic activity in the HD model used in this study. Results: We showed that AUTEN-67 treatment interferes with the progressive accumulation of ubiquitinated proteins in the brain of Drosophila transgenic for the pathological 128Q form of human Huntingtin protein. The compound significantly improved the climbing ability and moderately extended the mean life span of these flies. Furthermore, brain tissue samples from human patients diagnosed for HD displayed increased levels of the autophagy substrate SQSTM1/p62 protein, as compared with controls. Conclusions: These results imply that AUTEN-67 impedes the progression of neurodegenerative symptoms characterizing HD, and that autophagy is a promising therapeutic target for treating this pathology. In humans, AUTEN-67 may have the potential to delay the onset and decrease the severity of HD.
Keywords: Huntington’s disease, Huntingtin, polyQ, neurodegeneration, autophagy, AUTEN-67, Drosophila, climbing assay, ubiquitinated proteins, Ref(2)P/SQSTM1/p62
DOI: 10.3233/JHD-150180
Journal: Journal of Huntington's Disease, vol. 5, no. 2, pp. 133-147, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl